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1052-5157/14  2014 PublRoy Soetikno, MDEditorsIt is now evident that the nonpolypoid precancers contribute significantly in the devel-
opment of cancers throughout the gastrointestinal tract. Unfortunately, their detection,
diagnosis, and treatment continue to represent a major problem to endoscopists. The
human toll from our inability to prevent the development of many advanced colorectal
cancers is highest in inflammatory bowel disease (IBD), in proportion to the number of
patients undergoing screening. Therefore, the purpose of this issue is to start a
renewal—a renaissance—in the field of colonoscopy in patients with IBD.
The challenge to a renaissance in endoscopic imaging is significant because of the
seed that was planted some three decades ago. As video endoscopy was introduced,
our endoscopy forefathers chose the color charge coupled device (CCD), while their
Japanese counterparts used the black and white (B&W) CCD. The color CCD provided
a lower resolution video, but was preferred because it used white light that was more
pleasing to the eyes. The B&W CCD, on the other hand, used sequential red, green,
and blue lights, which provides a superior imaging. However, it can appear to flicker
and thus is less pleasing. With the lower quality endoscope imaging, western endo-
scopists have come to rely more on text and pathology to describe their findings,
rather than on the detailed images. Thus, in the United States, the nonpolypoid pre-
cancers and early cancers were not appreciated. The techniques to enhance visualiza-
tion of the nonpolypoid tumors were not prioritized, as few were found. Endoscopic
mucosal resection techniques were not routine in the practice of endoscopy; there
was no flat lesion to cut.
Since then, our CCD and endoscopy technology have significantly improved. With it
came the recognition of the importance of the nonpolypoid tumors. But, generations of
endoscopists were never taught the detection, diagnosis, or treatment techniques of
the nonpolypoids. Thus, today, in the United States, we find ourselves with IBD prac-
tice guidelines that are outdated and endoscopy techniques that are largely ineffective.
Of utmost concern, we lack the manuals and only have few teachers to disseminate the
renewals. How are we then going to move forward?
The ubiquitous use of the electronic media may provide one avenue. We are
indebted for the opportunity given by Dr Lightdale to prepare this issue, and to
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Prefacexvithankful to the Maxine and Jack Zarrow Family Foundation for their support to make
this issue free online as a resource for all patients and health providers. Renaissance in
endoscopic imaging in IBD can only begin when the patients demand, and the pro-
viders are able to deliver, the required care. Our sincere hope is that this (electronic)
issue and atlas provide the first of the new guides in endoscopy for IBD. Thus, we
can move forward and fulfill our promise—the Hippocratic Oath—to the fullest:
“I will apply, for the benefit of the sick, all measures [that] are required..” In the sur-
veillance for colorectal neoplasms in patients with IBD, the art and science of the
detection, diagnosis, and treatment of the nonpolypoid precancers and early cancers
are required. We need to make them standard practice.
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